Drug
Camrelizumab For
Camrelizumab For: highest development phase Phase 2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| Camrelizumab for Injection, Famitinib malate capsule, Paclitaxel For Injection(Albumin Bound) NCT05214976 | Phase 2 | Advanced Solid Tumors |
Latest
No recent events.
Follow Camrelizumab For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.